Overview
Our group develops innovative biotechnology and nanotechnology solutions for health, advancing the field of regenerative medicine. We design and evaluate advanced therapy medicinal products (ATMPs), stem cell therapies and implantable medical devices, targeting the restoration of bone, osteoarticular, periodontal, dental and ocular structures damaged by trauma, disease or aging. From electrospinning to smart drug delivery systems, including 3D bio-printing and advanced preclinical models, our translational and multidisciplinary research transforms biotechnological breakthroughs into concrete, safe and personalized therapeutic solutions. Our research strategy also relies on expertise in public health and epidemiology, particularly in the field of rare diseases, to ensure each innovation is grounded in a perspective of real and sustainable patient-centered benefits. This approach is complemented by a strong commitment to technology transfer and start-up creation, opening direct applications of our innovations to patient-relevant conditions.